Tuesday, March 17

Healthcare

Invivyd down 18% despite Pemgarda COVID risk reduction data

08/28/20241 Min Read

COVID data Invivyd Pemgarda reduction risk

Previous ArticleWalgreens, Hims stocks drop as Lilly rolls out cheap weight-loss drugs

Next Article Aadi Bioscience downgraded to Neutral, shares fall